BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38127072)

  • 1. Radiological findings in poisoning by synthetic cannabinoids adulterated with brodifacoum.
    Bar N; Lopez-Alonso R; Merhav G; Naaman E; Leiderman M; Ilivitzki A; Lurie Y; Kurnik D; Abadi S
    Eur Radiol; 2024 Jul; 34(7):4540-4549. PubMed ID: 38127072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bad weed: synthetic cannabinoid-associated coagulopathy.
    Arepally GM; Ortel TL
    Blood; 2019 Feb; 133(9):902-905. PubMed ID: 30655273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An outbreak of severe coagulopathy in northern Israel among users of illicit synthetic cannabinoids adulterated with brodifacoum.
    Lurie Y; Nadir Y; Hoffman R; Miller A; Efrati E; Ring G; Sonenfeld D; Bar N; Zaidani H; Strizevsky A; Asali M; Lavon O; Kurnik D
    Clin Toxicol (Phila); 2023 Jun; 61(6):429-435. PubMed ID: 37293741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Outbreak of Synthetic Cannabinoid-Associated Coagulopathy in Illinois.
    Kelkar AH; Smith NA; Martial A; Moole H; Tarantino MD; Roberts JC
    N Engl J Med; 2018 Sep; 379(13):1216-1223. PubMed ID: 30280655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids.
    Feinstein DL; Nosal DG; Ramanathan S; Zhou J; Chen L; Hershow RC; van Breemen RB; Wright E; Hafner JW; Rubinstein I
    Clin Toxicol (Phila); 2020 Jul; 58(7):716-724. PubMed ID: 31736367
    [No Abstract]   [Full Text] [Related]  

  • 6. Brodifacoum-contaminated synthetic marijuana: clinical and radiologic manifestations of a public health outbreak causing life-threatening coagulopathy.
    Panigrahi B; Jones BC; Rowe SP
    Emerg Radiol; 2018 Dec; 25(6):715-718. PubMed ID: 30022308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brodifacoum Poisoning Linked to Synthetic Marijuana Use in Wisconsin.
    Kircher M; Perez J
    WMJ; 2020 Jun; 119(2):129-131. PubMed ID: 32659068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Cannabinoid-Associated Coagulopathy: Case Report.
    Micula-Gondek W; Ruales V; Zorn C; Angelino A
    Psychosomatics; 2019; 60(2):211-215. PubMed ID: 30104022
    [No Abstract]   [Full Text] [Related]  

  • 9. Coagulopathic hemorrhage with use of synthetic cannabinoids.
    Boyack I; Opsha O
    Am J Emerg Med; 2019 Feb; 37(2):374.e3-374.e4. PubMed ID: 30409461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to Long-Term Follow-Up of Patients with Life-Threatening, Inhaled Synthetic Cannabinoids-Associated Coagulopathy in Chicago.
    Tole M; LaBedz S; Feinstein DL; Rubinstein I
    Lung; 2019 Jun; 197(3):349-352. PubMed ID: 31004190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorrhagic Soft Tissue Upper Airway Obstruction From Brodifacoum-Contaminated Synthetic Cannabinoid.
    Ross CH; Singh P; Simon EL
    J Emerg Med; 2019 Jul; 57(1):47-50. PubMed ID: 31078349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: Observational case series and management recommendations.
    Bahouth MN; Kraus P; Dane K; Plazas Montana M; Tsao W; Tabaac B; Jasem J; Schmidlin H; Einstein E; Streiff MB; Shanbhag S
    Medicine (Baltimore); 2019 Sep; 98(36):e17015. PubMed ID: 31490385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Study of the Characteristics of Anticoagulant-Type Rodenticide Poisoning in Hong Kong.
    Ng WY; Ching CK; Chong YK; Ng SW; Cheung WL; Mak TWL
    J Med Toxicol; 2018 Sep; 14(3):218-228. PubMed ID: 29687220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acquired hemorrhagic coagulopathy due to contact with the rodenticide brodifacoum in the Nutcracker bait].
    Voĭtsekhovskiĭ VV; Pivnik AV; Bitiutskaia LG; Protsko TT
    Ter Arkh; 2012; 84(7):66-71. PubMed ID: 23038975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds.
    Sznitman SR; Pinsky-Talbi L; Salameh M; Moed T; Bentur Y
    Int J Drug Policy; 2020 Mar; 77():102711. PubMed ID: 32126489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of severe coagulopathy from synthetic cannabinoids tainted with Long-Acting anticoagulant rodenticides.
    Devgun JM; Rasin A; Kim T; Mycyk MB; Bryant SM; Wahl MS; DesLauriers C; Navon L; Moritz ED; Thompson TM; Swoboda HD; Lu J; Aks SE
    Clin Toxicol (Phila); 2020 Aug; 58(8):821-828. PubMed ID: 31797705
    [No Abstract]   [Full Text] [Related]  

  • 17. Coagulopathy After Synthetic Cannabinoid Use: A Case Report.
    Rasin A; Devgun JM; Nosal DG; Meehan TJ; van Breemen RB; Thompson TM
    Ann Intern Med; 2019 Oct; 171(8):595-596. PubMed ID: 31450243
    [No Abstract]   [Full Text] [Related]  

  • 18. Prolonged coagulopathy after brodifacoum exposure.
    Underwood EL; Sutton J; Ellis IK; Qualls B; Zamber J; Walker BN
    Am J Health Syst Pharm; 2014 Apr; 71(8):639-42. PubMed ID: 24688037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulopathy associated with superwarfarin exposure.
    Moery S; Pontious JM
    J Okla State Med Assoc; 2009 Oct; 102(10):323-5. PubMed ID: 19998733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brodifacoum contamination of synthetic cannabinoid causing unexplained coagulopathy in multiple trauma: A case report.
    Thomas AV; Johnson ML; Tincher AM; Zackariya S; Khan H; Rizvi U; Thomas SG; Noveroske TW; Fulkerson DH; Moore EE; Walsh MM
    Trauma Case Rep; 2024 Jun; 51():101007. PubMed ID: 38590923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.